Regeneron: Independent committee recommends holding trial enrollment in hospitalized patients with high oxygen requirements

REGN-COV2 independent data monitoring committee recommends holding enrollment in hospitalized patients with high oxygen requirements and continuing enrollment in patients with low or no oxygen requirements – Regeneron

Commentary on Twitter

More potential evidence against antibody drugs late in course of #COVID19: Regeneron says independent cmte has recommended not enrolling pts on high oxygen into trial "based on a potential safety signal and an unfavorable risk/benefit profile at this time" https://t.co/moHtuhV9cP

— Meg Tirrell (@megtirrell) October 30, 2020